Featured Post
Why Automation Is Growing in Non-Sterile Compounding in the USA
Non-sterile compounding automation is reshaping how independent pharmacies in the United States operate. Driven by a convergence of regulatory demands, workforce constraints, and rising patient demand for personalized dosing, compounding pharmacy automation has moved from a niche consideration to a strategic priority for private pharmacies looking to remain competitive and compliant in 2026 and beyond.
-3.png)
Evaluation of CurifyLabs Technology in the European Journal of Pharmaceutical Sciences
Transforming Pediatric Care with CurifyLabs' Automated Compounding System, European Journal of Pharmaceutical Sciences
Women's Health and the Transformative Role of Personalized Medicine
Women's health CurifyLabs personalized medicines
Developing Technologies that Benefit All Payors in Healthcare: A Path to a More Efficient and Affordable System
Costs and return on investment CurifyLabs
.jpeg)
Läkartidningen: 3D-Printed Medications to Fill Gaps in Swedish Market
Läkartidningen on 3D printing of medicines
ROI Video: How Much Time Can a Pharmacist Save in Compounding Using the CurifyLabs Pharma Kit?
ROI on CurifyLabs technology - manual compounding VS automated compounding with the Pharma Kit
APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology
CurifyLabs to partner with APL
